CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer
Ah-Rong Nam, Mei Hua Jin, Ji Eun Park, Ju-Hee Bang, Do-Youn Oh, Yung-Jue Bang
Cancer Research and Treatment. 2019;51(3):1167-1179.   Published online 2018 December 3    DOI: https://doi.org/10.4143/crt.2018.526

Excel Download

Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer
Cancer Research and Treatment. 2019;51(3):1167-1179   Crossref logo
Link1 Link2 Link3

Targeting ATR for Cancer Therapy: ATR-Targeted Drug Candidates
Targeting the DNA Damage Response for Anti-Cancer Therapy. 2018;99-127   Crossref logo
Link1

Targeting ATR for Cancer Therapy: Profile and Expectations for ATR Inhibitors
Targeting the DNA Damage Response for Anti-Cancer Therapy. 2018;63-97   Crossref logo
Link1

Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer
British Journal of Pharmacology. 2013;169(8):1745-1765   Crossref logo
Link1 Link2

Control of DNA Replication by ATR
Targeting the DNA Damage Response for Anti-Cancer Therapy. 2018;35-61   Crossref logo
Link1

Advances in therapeutic targeting of the DNA damage response in cancer
DNA Repair. 2018;66-67:24-29   Crossref logo
Link1 Link2

Targeting the DNA-damage response as a therapeutic strategy
European Journal of Cancer Supplements. 2008;6(9):119   Crossref logo
Link1 Link2

Targeting DNA-PK as a Therapeutic Approach in Oncology
Targeting the DNA Damage Response for Anti-Cancer Therapy. 2018;339-357   Crossref logo
Link1

Preclinical Investigation of Inhibition of the DNA Damage Response as a Targetted Therapy in Myeloproliferative Neoplasms Shows Synergism of ATR Inhibitors with Standard-of-Care Treatment
The 1st International Electronic Conference on Cancers: Exploiting Cancer Vulnerability by Targeting the DNA Damage Response. 2021;   Crossref logo
Link1

ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancer
Therapeutic Advances in Medical Oncology. 2020;12:175883592098285   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.